EPRX

Eupraxia Pharmaceuticals is a clinical-stage biotechnology company developing locally delivered extended-release products for pain management and inflammatory conditions. The company's proprietary DiffuSphere drug delivery technology platform enables the sustained release of therapeutic agents at the site of disease. Eupraxia's lead product candidates target conditions such as osteoarthritis pain and post-surgical pain. The company focuses on developing non-opioid treatment options that can provide pain relief for weeks or months from a single administration.